What is M-end and its Mission?

Dr. Susan Busse helping child with malaria

M-end is a program about ending malaria and changing the lives of those whose families have suffered with it for many generations. It is about bringing healing to individuals, villages, and countries both spiritually and physically to create positive change no matter what their individual economic status. It is about mending both bodies and souls, so they can live healthy and productive lives. It is about working with governments, churches and clinicians to reduce the risk faced by millions of people dying of malaria every year, with the majority of those being young children. M-end is about restoring lives and ending a disease that has plagued mankind for over thousands of years. M-end is a not-for-profit organization that is about clinically eradicating malaria while introducing faith into the lives of those who are renewed to new health.

Our History

The origins of this program came out of the nonmedical efforts of a geologist who needed to travel to malaria infested areas. He and his team on occasion would contract malaria in places where medical treatment was unavailable. It was under these circumstances that the team found that the same treatment they were using to sanitize their water was effective in rapidly ending their malaria symptoms. The elements of this treatment were refined by Dr. Hesselink and then incorporated into the kits of clinicians who were doing medical mission work in Africa. Since the treatment components are compact and do not need refrigeration they are easy to take into the rural areas where populations are hit hardest by the risk of malaria and unclean drinking water.

In 2007, Physicians Susan Busse and Thomas Hesselink along with chemical engineer John Peterson began to work with this oral treatment on medical mission trips, originally calling the program the Malaria Initiative. The Malaria Initiative in 2011 was renamed M-END, giving it its own identity as a nonprofit organization dedicated to restoring lives and ending malaria. The next step of this program is to begin formal clinical trials this fall so it can be introduced into treatment protocols worldwide as an accepted treatment for malaria.

The treatment is administered orally to eradicate malaria from an individual’s blood stream. Costing less than five U.S. pennies per dose, the materials consist of two packets, one weighing 10 grams and the other 20 grams making the basic chemical mixture remarkably portable, fitting easily into a shirt pocket. This allows easy distribution and those two tiny packets can treat 200-400 people. (For complete scientific information and credentials of the founding directors, please turn to the organizational information section).

Our Founding Directors

Susan Busse, M.D. Susan Busse, M.D., Founder
Susan K. Busse is a Board certified family medicine physician who graduated from Rush Medical College in 1991 with clinical high honors. After she completed her residency from LaGrange Memorial Hospital, Dr. Busse opened Busse Wellness Center, Ltd., an integrative natural healing center utilizing many innovative modalities such as oxidative treatments, detoxification for heavy metals, bio-identical hormone balancing, nutritional intravenous solutions, state-of-the art allergy testing, and bowel restoration programs. In addition, she became widely recognized for her expertise in difficult to diagnose cases, particularly vector borne infectious illnesses.
 
Since 1996, she has been serving countries that are economically underdeveloped by participation in short-term medical missions. Some of these missions have been following a natural disaster such as a hurricane or earthquake. Countries have included Dominican Republic, Honduras, Uganda, Ghana, Kenya, Peru, Mexico, India, Sierra Leone, Ethiopia and Haiti.
 
Before her medical mission to Uganda in 2007, Dr. Busse was contacted by Dr. Tom Hesselink about an innovative malaria treatment he had been researching for several years, that has the potential to change the face of Africa. By using two simple ingredients that deprive the plasmodium parasite from heme, its favored food source, this oxidative mechanism removes malaria from the blood stream. Dr Busse is now involved in gaining support for formal clinical trials to be able to make this treatment option available to clinicians treating populations at risk.
 
John Peterson John Peterson, Founder
Mr. Peterson, a graduate of Western Illinois University, went to work heading a chemical reclamation plant for 13 years. Then he started an environmental company that pioneered the use of microbes that eat oil and gasoline which contaminates soil and water. John Peterson then went on to found a medical research and clinical facility which specialized in fastidious infectious diseases. He was the first to succeed doing this commercially and helped write the Environmental Protection Agency (EPA) guide lines. He continued to advance science through his development of new technologies in DNA sequencing and bacterial sensitivity to antibiotics resulting in several new medical patents.
 
He became involved with Dr Busse and Hesselink in their work with using this new treatment for malaria through medical missions. Seeing the efficacy of this efficient treatment Mr. Peterson is now dedicated to making this option available to in countries where populations are at risk.
 
Thomas Hesselink, M.D. Thomas Hesselink, M.D., Founder
Dr. Hesselink received his B.A. in biochemistry from Northwestern University in Evanston, Illinois and went on to attend the University of Illinois. He did his family practice residency program in Flint, Michigan. From 1978 to 1981 he provided nutritional and preventive services in Zion, Illinois. There he met other integrative practitioners, who introduced him to a wider variety of alternatives. These include: intravenous chelation therapy, alternative cancer therapies, clinical ecology, and Koch’s therapy.
 
In 1991 Dr. Hesselink’s interest in Koch’s therapy was rekindled, whereupon, he embarked on a quest to discover and to explain how this therapy worked. He devoted several thousand hours of time studying in hospital and university libraries, performing literature searches, and collecting references. He succeeded in developing a unified theory to explain the mechanisms behind this and the other oxidative therapies. In 2006, he focused his interest in therapies associated with the oxides of chlorine where he proposed an explanation for how chlorine dioxide was working to treat malaria and other infections.
 
He is asked to speak regularly at the International Oxidative Medical Association (IOMA) and American College for the Advancement of Medicine (ACAM) conferences and workshops. These organizations review: hyperbaric oxygenation, ultraviolet hemoirradiation, ozone, antioxidants, oxidative catalysts, hydrogen peroxide, megadose ascorbate, chlorine dioxide, sodium chlorite, iodine and related therapies. His focus, as a speaker, is on the explanations of the biochemistry of oxidative medicine and the appropriate application
of antioxidants.